Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL

Completed

Conditions studied: Cataract

In brief

To evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery.

Key facts

Study ID

NCT02394379

Run by

Bausch & Lomb Incorporated

People needed

600

Starts

2015-03-19

Expected to finish

2019-08-05

Last updated by the study team

2019-11-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are able and willing to comply with the follow-up schedule
• Subjects must have a clinically documented diagnosis of age-related cataract that is considered amenable to treatment with standard phacoemulsification/extracapsular cataract extraction
• Subjects must require a lens power from 4 to 33 D
• Subjects must have a Best Corrected Visual Acuity (BCVA) equal to or worse than 20/40, with or without a glare source

You may not qualify if…

• Subjects with any anterior segment pathology in the study eye likely to increase the risk of complications from phacoemulsification cataract surgery
• Subjects with associated ocular conditions which could affect the stability of the IOL
• Subjects with clinically significant irregular corneal astigmatism in the study eye

Where it is running

• Bausch & Lomb Incorporated — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.